2020-2025 Global Multiple Myeloma Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

July 2021 | 129 pages | ID: 2772A491391DEN
Maia Research

Abstracts

This report elaborates the market size, market characteristics, and market growth of the Multiple Myeloma Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Myeloma Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Multiple Myeloma Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Multiple Myeloma Drugs market covered in Chapter 13:
Teva
Johnson & Johnson
Merck
Amgen
PharmaMar
Bristol Myers Squibb
Daiichi Sankyo
Takeda Pharmaceutical
AB Science
Celgene
Novartis

In Chapter 6, on the basis of types, the Multiple Myeloma Drugs market from 2015 to 2025 is primarily split into:
Immunomodulatory Drugs
Proteasome Inhibitors
Chemotherapy
Histone Deacetylase Inhibitor
Steroids

In Chapter 7, on the basis of applications, the Multiple Myeloma Drugs market from 2015 to 2025 covers:
Targeted Therapy
Biologic Therapy
Chemotherapy

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 MULTIPLE MYELOMA DRUGS MARKET - RESEARCH SCOPE

1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 MULTIPLE MYELOMA DRUGS MARKET - RESEARCH METHODOLOGY

2.1 Methodology
2.2 Research Data Source
  2.2.1 Secondary Data
  2.2.2 Primary Data
  2.2.3 Market Size Estimation
  2.2.4 Legal Disclaimer

3 MULTIPLE MYELOMA DRUGS MARKET FORCES

3.1 Global Multiple Myeloma Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
  3.2.1 Political Factors
  3.2.2 Economic Factors
  3.2.3 Social Factors
  3.2.4 Technological Factors
  3.2.5 Environmental Factors
  3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
  3.4.1 Risk Assessment on COVID-19
  3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
  3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 MULTIPLE MYELOMA DRUGS MARKET - BY GEOGRAPHY

4.1 Global Multiple Myeloma Drugs Market Value and Market Share by Regions
  4.1.1 Global Multiple Myeloma Drugs Value ($) by Region (2015-2020)
  4.1.2 Global Multiple Myeloma Drugs Value Market Share by Regions (2015-2020)
4.2 Global Multiple Myeloma Drugs Market Production and Market Share by Major Countries
  4.2.1 Global Multiple Myeloma Drugs Production by Major Countries (2015-2020)
  4.2.2 Global Multiple Myeloma Drugs Production Market Share by Major Countries (2015-2020)
4.3 Global Multiple Myeloma Drugs Market Consumption and Market Share by Regions
  4.3.1 Global Multiple Myeloma Drugs Consumption by Regions (2015-2020)
  4.3.2 Global Multiple Myeloma Drugs Consumption Market Share by Regions (2015-2020)

5 MULTIPLE MYELOMA DRUGS MARKET - BY TRADE STATISTICS

5.1 Global Multiple Myeloma Drugs Export and Import
5.2 United States Multiple Myeloma Drugs Export and Import (2015-2020)
5.3 Europe Multiple Myeloma Drugs Export and Import (2015-2020)
5.4 China Multiple Myeloma Drugs Export and Import (2015-2020)
5.5 Japan Multiple Myeloma Drugs Export and Import (2015-2020)
5.6 India Multiple Myeloma Drugs Export and Import (2015-2020)
5.7 ...

6 MULTIPLE MYELOMA DRUGS MARKET - BY TYPE

6.1 Global Multiple Myeloma Drugs Production and Market Share by Types (2015-2020)
  6.1.1 Global Multiple Myeloma Drugs Production by Types (2015-2020)
  6.1.2 Global Multiple Myeloma Drugs Production Market Share by Types (2015-2020)
6.2 Global Multiple Myeloma Drugs Value and Market Share by Types (2015-2020)
  6.2.1 Global Multiple Myeloma Drugs Value by Types (2015-2020)
  6.2.2 Global Multiple Myeloma Drugs Value Market Share by Types (2015-2020)
6.3 Global Multiple Myeloma Drugs Production, Price and Growth Rate of Immunomodulatory Drugs (2015-2020)
6.4 Global Multiple Myeloma Drugs Production, Price and Growth Rate of Proteasome Inhibitors (2015-2020)
6.5 Global Multiple Myeloma Drugs Production, Price and Growth Rate of Chemotherapy (2015-2020)
6.6 Global Multiple Myeloma Drugs Production, Price and Growth Rate of Histone Deacetylase Inhibitor (2015-2020)
6.7 Global Multiple Myeloma Drugs Production, Price and Growth Rate of Steroids (2015-2020)

7 MULTIPLE MYELOMA DRUGS MARKET - BY APPLICATION

7.1 Global Multiple Myeloma Drugs Consumption and Market Share by Applications (2015-2020)
  7.1.1 Global Multiple Myeloma Drugs Consumption by Applications (2015-2020)
  7.1.2 Global Multiple Myeloma Drugs Consumption Market Share by Applications (2015-2020)
7.2 Global Multiple Myeloma Drugs Consumption and Growth Rate of Targeted Therapy (2015-2020)
7.3 Global Multiple Myeloma Drugs Consumption and Growth Rate of Biologic Therapy (2015-2020)
7.4 Global Multiple Myeloma Drugs Consumption and Growth Rate of Chemotherapy (2015-2020)

8 NORTH AMERICA MULTIPLE MYELOMA DRUGS MARKET

8.1 North America Multiple Myeloma Drugs Market Size
8.2 United States Multiple Myeloma Drugs Market Size
8.3 Canada Multiple Myeloma Drugs Market Size
8.4 Mexico Multiple Myeloma Drugs Market Size
8.5 The Influence of COVID-19 on North America Market

9 EUROPE MULTIPLE MYELOMA DRUGS MARKET ANALYSIS

9.1 Europe Multiple Myeloma Drugs Market Size
9.2 Germany Multiple Myeloma Drugs Market Size
9.3 United Kingdom Multiple Myeloma Drugs Market Size
9.4 France Multiple Myeloma Drugs Market Size
9.5 Italy Multiple Myeloma Drugs Market Size
9.6 Spain Multiple Myeloma Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market

10 ASIA-PACIFIC MULTIPLE MYELOMA DRUGS MARKET ANALYSIS

10.1 Asia-Pacific Multiple Myeloma Drugs Market Size
10.2 China Multiple Myeloma Drugs Market Size
10.3 Japan Multiple Myeloma Drugs Market Size
10.4 South Korea Multiple Myeloma Drugs Market Size
10.5 Southeast Asia Multiple Myeloma Drugs Market Size
10.6 India Multiple Myeloma Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 MIDDLE EAST AND AFRICA MULTIPLE MYELOMA DRUGS MARKET ANALYSIS

11.1 Middle East and Africa Multiple Myeloma Drugs Market Size
11.2 Saudi Arabia Multiple Myeloma Drugs Market Size
11.3 UAE Multiple Myeloma Drugs Market Size
11.4 South Africa Multiple Myeloma Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 SOUTH AMERICA MULTIPLE MYELOMA DRUGS MARKET ANALYSIS

12.1 South America Multiple Myeloma Drugs Market Size
12.2 Brazil Multiple Myeloma Drugs Market Size
12.3 The Influence of COVID-19 on South America Market

13 COMPANY PROFILES

13.1 Teva
  13.1.1 Teva Basic Information
  13.1.2 Teva Product Profiles, Application and Specification
  13.1.3 Teva Multiple Myeloma Drugs Market Performance (2015-2020)
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Basic Information
  13.2.2 Johnson & Johnson Product Profiles, Application and Specification
  13.2.3 Johnson & Johnson Multiple Myeloma Drugs Market Performance (2015-2020)
13.3 Merck
  13.3.1 Merck Basic Information
  13.3.2 Merck Product Profiles, Application and Specification
  13.3.3 Merck Multiple Myeloma Drugs Market Performance (2015-2020)
13.4 Amgen
  13.4.1 Amgen Basic Information
  13.4.2 Amgen Product Profiles, Application and Specification
  13.4.3 Amgen Multiple Myeloma Drugs Market Performance (2015-2020)
13.5 PharmaMar
  13.5.1 PharmaMar Basic Information
  13.5.2 PharmaMar Product Profiles, Application and Specification
  13.5.3 PharmaMar Multiple Myeloma Drugs Market Performance (2015-2020)
13.6 Bristol Myers Squibb
  13.6.1 Bristol Myers Squibb Basic Information
  13.6.2 Bristol Myers Squibb Product Profiles, Application and Specification
  13.6.3 Bristol Myers Squibb Multiple Myeloma Drugs Market Performance (2015-2020)
13.7 Daiichi Sankyo
  13.7.1 Daiichi Sankyo Basic Information
  13.7.2 Daiichi Sankyo Product Profiles, Application and Specification
  13.7.3 Daiichi Sankyo Multiple Myeloma Drugs Market Performance (2015-2020)
13.8 Takeda Pharmaceutical
  13.8.1 Takeda Pharmaceutical Basic Information
  13.8.2 Takeda Pharmaceutical Product Profiles, Application and Specification
  13.8.3 Takeda Pharmaceutical Multiple Myeloma Drugs Market Performance (2015-2020)
13.9 AB Science
  13.9.1 AB Science Basic Information
  13.9.2 AB Science Product Profiles, Application and Specification
  13.9.3 AB Science Multiple Myeloma Drugs Market Performance (2015-2020)
13.10 Celgene
  13.10.1 Celgene Basic Information
  13.10.2 Celgene Product Profiles, Application and Specification
  13.10.3 Celgene Multiple Myeloma Drugs Market Performance (2015-2020)
13.11 Novartis
  13.11.1 Novartis Basic Information
  13.11.2 Novartis Product Profiles, Application and Specification
  13.11.3 Novartis Multiple Myeloma Drugs Market Performance (2015-2020)

14 MARKET FORECAST - BY REGIONS

14.1 North America Multiple Myeloma Drugs Market Forecast (2020-2025)
14.2 Europe Multiple Myeloma Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Multiple Myeloma Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Multiple Myeloma Drugs Market Forecast (2020-2025)
14.5 South America Multiple Myeloma Drugs Market Forecast (2020-2025)

15 MARKET FORECAST - BY TYPE AND APPLICATIONS

15.1 Global Multiple Myeloma Drugs Market Forecast by Types (2020-2025)
  15.1.1 Global Multiple Myeloma Drugs Market Forecast Production and Market Share by Types (2020-2025)
  15.1.2 Global Multiple Myeloma Drugs Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Multiple Myeloma Drugs Market Forecast by Applications (2020-2025)

List Of Tables

LIST OF TABLES AND FIGURES

Figure Multiple Myeloma Drugs Picture
Table Multiple Myeloma Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Multiple Myeloma Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Multiple Myeloma Drugs Value ($) and Growth Rate (2015-2020)
Table Global Multiple Myeloma Drugs Value ($) by Countries (2015-2020)
Table Global Multiple Myeloma Drugs Value Market Share by Regions (2015-2020)
Figure Global Multiple Myeloma Drugs Value Market Share by Regions in 2019
Figure Global Multiple Myeloma Drugs Production and Growth Rate (2015-2020)
Table Global Multiple Myeloma Drugs Production by Major Countries (2015-2020)
Table Global Multiple Myeloma Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Multiple Myeloma Drugs Production Market Share by Regions in 2019
Figure Global Multiple Myeloma Drugs Consumption and Growth Rate (2015-2020)
Table Global Multiple Myeloma Drugs Consumption by Regions (2015-2020)
Table Global Multiple Myeloma Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Multiple Myeloma Drugs Consumption Market Share by Regions in 2019
Table Global Multiple Myeloma Drugs Export Top 3 Country 2019
Table Global Multiple Myeloma Drugs Import Top 3 Country 2019
Table United States Multiple Myeloma Drugs Export and Import (2015-2020)
Table Europe Multiple Myeloma Drugs Export and Import (2015-2020)
Table China Multiple Myeloma Drugs Export and Import (2015-2020)
Table Japan Multiple Myeloma Drugs Export and Import (2015-2020)
Table India Multiple Myeloma Drugs Export and Import (2015-2020)
Table Global Multiple Myeloma Drugs Production by Types (2015-2020)
Table Global Multiple Myeloma Drugs Production Market Share by Types (2015-2020)
Figure Global Multiple Myeloma Drugs Production Share by Type (2015-2020)
Table Global Multiple Myeloma Drugs Value by Types (2015-2020)
Table Global Multiple Myeloma Drugs Value Market Share by Types (2015-2020)
Figure Global Multiple Myeloma Drugs Value Share by Type (2015-2020)
Figure Global Immunomodulatory Drugs Production and Growth Rate (2015-2020)
Figure Global Immunomodulatory Drugs Price (2015-2020)
Figure Global Proteasome Inhibitors Production and Growth Rate (2015-2020)
Figure Global Proteasome Inhibitors Price (2015-2020)
Figure Global Chemotherapy Production and Growth Rate (2015-2020)
Figure Global Chemotherapy Price (2015-2020)
Figure Global Histone Deacetylase Inhibitor Production and Growth Rate (2015-2020)
Figure Global Histone Deacetylase Inhibitor Price (2015-2020)
Figure Global Steroids Production and Growth Rate (2015-2020)
Figure Global Steroids Price (2015-2020)
Table Global Multiple Myeloma Drugs Consumption by Applications (2015-2020)
Table Global Multiple Myeloma Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Multiple Myeloma Drugs Consumption Share by Application (2015-2020)
Figure Global Targeted Therapy Consumption and Growth Rate (2015-2020)
Figure Global Biologic Therapy Consumption and Growth Rate (2015-2020)
Figure Global Chemotherapy Consumption and Growth Rate (2015-2020)
Figure North America Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Multiple Myeloma Drugs Consumption by Countries (2015-2020)
Table North America Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Multiple Myeloma Drugs Consumption by Countries (2015-2020)
Table Europe Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Multiple Myeloma Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure China Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Multiple Myeloma Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Multiple Myeloma Drugs Consumption by Countries (2015-2020)
Table South America Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Multiple Myeloma Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Multiple Myeloma Drugs Market Consumption and Growth Rate (2015-2020)
Table Teva Company Profile
Table Teva Production, Value, Price, Gross Margin 2015-2020
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2015-2020
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Production, Value, Price, Gross Margin 2015-2020
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2015-2020
Table PharmaMar Company Profile
Table PharmaMar Production, Value, Price, Gross Margin 2015-2020
Figure PharmaMar Production and Growth Rate
Figure PharmaMar Value ($) Market Share 2015-2020
Table Bristol Myers Squibb Company Profile
Table Bristol Myers Squibb Production, Value, Price, Gross Margin 2015-2020
Figure Bristol Myers Squibb Production and Growth Rate
Figure Bristol Myers Squibb Value ($) Market Share 2015-2020
Table Daiichi Sankyo Company Profile
Table Daiichi Sankyo Production, Value, Price, Gross Margin 2015-2020
Figure Daiichi Sankyo Production and Growth Rate
Figure Daiichi Sankyo Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Profile
Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
Figure Takeda Pharmaceutical Production and Growth Rate
Figure Takeda Pharmaceutical Value ($) Market Share 2015-2020
Table AB Science Company Profile
Table AB Science Production, Value, Price, Gross Margin 2015-2020
Figure AB Science Production and Growth Rate
Figure AB Science Value ($) Market Share 2015-2020
Table Celgene Company Profile
Table Celgene Production, Value, Price, Gross Margin 2015-2020
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Production, Value, Price, Gross Margin 2015-2020
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Production by Types (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Multiple Myeloma Drugs Market Forecast Consumption Share by Applications (2020-2025)